[1] Harries L. MicroRNAs as mediators of the ageing process [J]. Genes(Basel), 2014, 5(3): 656-670.
[2] Akbari Dilmaghnai N, Shoorei H, Sharifi G, et al. Non-coding RNAs modulate function of extracellular matrix proteins [J]. Biomed Pharmacother, 2021,136: 111240.
[3] Ullmann P, Nurmik M, Schmitz M, et al. Tumor suppressor miR-215 counteracts hypoxia-induced colon cancer stem cell activity[J].Cancer Lett,2019,450:32-41.
[4] Hao ChX, Zhang XG, Li W, et al. Changes and diagnostic value of plasma Mir-122, Mir-29b and Mir-30D in patients with acute coronary syndrome[J]. Journal of Molecular Diagnostics and Therapy, 2021,13(5):762-765. (in Chinese)
郝春霞,张小光,李伟等.急性冠脉综合征患者血浆miR-122、miR-29b、miR-30d水平变化及诊断价值[J].分子诊断与治疗杂志,2021,13(5):762-765.
[5] Liu K, Xuekelati S, Zhou K, et al. Expression profiles of six atherosclerosis-associated microRNAs that cluster in patients with hyperhomocysteinemia. A clinical study[J]. DNA Cell Biol, 2018,37(3):189-198.
[6] Kim CK, Pak TR. miRNA degradation in the mammalian brain[J]. Am J Physiol Cell Physiol, 2020,319(4):C624-C629.
[7] Zhao MJ, Xie J, Shu WJ, et al. MiR-15b and miR-322 inhibit SETD3 expression to repress muscle cell differentiation[J]. Cell Death Dis, 2019,10(3):183.
[8]Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer[J]. Dis Model Mech, 2021,4(14):668-670.
[9] La Sala L, Cattaneo M, De Nigris V, et al. Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells[J]. Cardiovasc Diabetol, 2016,15:71-78.
[10]Kroliczewski J,Sobolewska A,Lejnowski D,et al.microRNA single polynucleotide polymorphism influences on microRNA biogenesis and mRNA target specificity[J].Gene,2018,640: 66-72.
[11]Kanthaje S, Baikunje N, Kandal I, et al. Repertoires of microRNA-30 family as gate-keepers in lung cancer[J]. Front Biosci (ScholEd),2021,13(2):141-156.
[12]Zhang X, Dong S, Jia Q, et al. The microRNA in ventricular remodeling: the miR-30 family[J]. Biosci Rep, 2019, 39(8):BSR20190788.
[13]Gu XX, Zeng ZhN, He YL, et al. Polymorphism of hypoxia inducer 3A gene rs11672731 and RS2072491 in Guangxi Han population [J]. Acta Anatomica Sinica, 2021,52(4):647-651. (in Chinese)
谷嬉嬉,曾志能,何永玲,等. 广西汉族人群中缺氧诱导因子3A基因rs11672731和rs2072491的多态性[J].解剖学报,2021,52(4):647-651.
[14]Huang YY, Huang HT, Lu YL, et al. Polymorphism of mirNA-107 gene and its relationship with blood lipid in Guangxi population [J]. Acta Anatomica Sinica,2020,51(2):284-288. (in Chinese)
黄艳云,黄华佗,陆玉兰,等.广西人群miRNA-107基因多态性分布特征及其与血脂的关系[J].解剖学报,2020,51(2):284-288.
[15]Fan Z, Peng W, Wang Z, et al. Identification of biomarkers associated with metabolic cardiovascular disease using mRNA-SNP-miRNA regulatory network analysis[J]. BMC Cardiovasc Disord,2021,21(1):351.
[16]Ghanbari M,Ikram MA,de Looper HW,et al.Genome-wide identification of microRNA-related variants associated with risk of Alzheimer’s disease[J].Sci Rep,2016,6: 28387.
[17]Zhou J, Wang L, Liu S, et al. Genetic variations in miR-30 family member regulatory regions are associated with breast cancer risk in a Chinese population[J]. Biomed Res Int,2020,2020:8781348
[18]Verma A, Mittal RD. Association of miRNA 30c, miRNA 181a and miRNA 570 SNPs with bladder cancer risk in North Indian population: a pilot study[J]. Indian J Clin Biochem,2021,36(2):194-199.
[19]Yang R, Hong H, Wang M, et al. Correlation between single-nucleotide polymorphisms within miR-30a and related target genes and risk or prognosis of nephrotic syndrome[J]. DNA Cell Biol,2018, 37(3):233-243.
[20]Mao L, Liu S, Hu L, et al. miR-30 family: a promising regulator in development and disease[J].BioMed Res Int,2018,2018: 9623412.
[21]Willer CJ, Schmidt EM, Sengupta S, et al. Discovery and refinement of loci associated with lipid levels[J]. Nat Genet,2013,45(11):1274-1283.
[22]Zhang T, Tian F, Wang J, et al. Endothelial cell autophagy in atherosclerosis is regulated by miR-30-mediated translational control of ATG6 [J]. Cell Physiol Biochem, 2015,37(4):1369-1378.
[23]Veitch S, Njock MS, Chandy M, et al. MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes[J]. Cardiovasc Diabetol, 2022,21(1):31.
[24]Zaragosi G, Ling Z, EJ, et al. Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis[J]. Genome Biol, 2020,12(7): R64.
|